Skip to content

Simcere Zaiming Pharmaceutical Co., Ltd., Insider at NextCure, sold NXTC on Aug 10, 2026

Data as of Oct 16

▼ SELL$185K30,000 shares at $6.16Simcere Zaiming Pharmaceutical Co., Ltd. InsiderNXTC NextCure, Inc.
Watch NXTC
Traded
Aug 10, 2026
Disclosed
Aug 12, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Simcere Zaiming Pharmaceutical Co., Ltd., Insider at NextCure, sold NXTC on Aug 10, 2026TRADEDDISCLOSED
NXTCSimilar stocks (XLV — its sector index fund), rebased to NXTC's price on the disclosure day
NXTC since disclosure
−23.6%
after the sale
Similar stocks (XLV) since disclosure
+4.9%
XLV — its sector index fund

Change in closing price from Aug 12, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLSimcere Pharmaceutical Group Ltd InsiderNXTC NextCure, Inc.$185Kdisclosed Aug 12 · filed 2 days after the trade
  2. ▼ SELLJinsheng Ren InsiderNXTC NextCure, Inc.$185Kdisclosed Aug 12 · filed 2 days after the trade
  3. ▼ SELLJiangsu Simcere Zaiming Pharmaceutical Co., Ltd. InsiderNXTC NextCure, Inc.$185Kdisclosed Aug 12 · filed 2 days after the trade
  4. ▼ SELLSimcere Zaiming, Inc. InsiderNXTC NextCure, Inc.$185Kdisclosed Aug 12 · filed 2 days after the trade
  5. ▼ SELLRenhong Tang InsiderNXTC NextCure, Inc.$185Kdisclosed Aug 12 · filed 2 days after the trade

See every trade on NXTC →